Skip to content

Drug interactions

DHEA + Dihydroergotamine

Severity: Moderate

DHEA and Dihydroergotamine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

DHEA is reported to affect CYP3A4, but evidence for a clinically relevant effect is weak. Dihydroergotamine is a CYP3A4 substrate with a risk of ergotism and vasospasm when levels rise.

What this interaction means in plain words

DHEA and Dihydroergotamine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

DHEA belongs to Gastrointestinal Tract; Dihydroergotamine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Possible CYP3A4 inhibition by DHEA raising dihydroergotamine levels; not well established.

What to do

Advise patients to avoid DHEA supplements during dihydroergotamine therapy. Monitor for numbness, coldness of extremities, or ischemic symptoms.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for DHEA and Dihydroergotamine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take DHEA with Dihydroergotamine?

MediHelp rates the interaction as moderate. DHEA and Dihydroergotamine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. DHEA is reported to affect CYP3A4, but evidence for a clinically relevant effect is weak. Dihydroergotamine is a CYP3A4 substrate with a risk of ergotism and vasospasm when levels rise.

How serious is the interaction between DHEA and Dihydroergotamine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Advise patients to avoid DHEA supplements during dihydroergotamine therapy. Monitor for numbness, coldness of extremities, or ischemic symptoms.

What other medicines interact with DHEA?

MediHelp also lists interactions of DHEA with, for example, Dihydroergotamine intranasal, Ergotamine, Pimozide. The full list is on the DHEA page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in